~11 spots leftby Apr 2026

Parent-Mediated Intervention for Autism Spectrum Disorder

(PRIMeR Trial)

Recruiting in Palo Alto (17 mi)
IM
Overseen byIsabel M Smith, PhD
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: IWK Health Centre
Disqualifiers: Severe sensory or motor impairment, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests two therapies for young children with autism who haven't responded well to usual treatments. The therapies involve parents playing with their children to encourage communication and social skills. One therapy focuses on general improvement, while the other targets specific weaknesses.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment PRIMeR for autism spectrum disorder?

Research shows that Pivotal Response Treatment (PRT), a key component of PRIMeR, is effective in improving communication and social skills in children with autism. Studies indicate that parents trained in PRT can help increase their children's speech and social interactions, making it a promising approach for autism treatment.12345

Is parent-mediated intervention for autism spectrum disorder safe for humans?

The studies reviewed focus on the effectiveness of parent-mediated interventions like Pivotal Response Treatment (PRT) and Natural Language Paradigm (NLP) for improving communication in children with autism. They do not report any safety concerns, suggesting these interventions are generally safe for use in humans.12367

How is the Parent-Mediated Intervention for Autism Spectrum Disorder treatment different from other treatments?

This treatment is unique because it involves training parents to use Pivotal Response Treatment (PRT) techniques at home, focusing on improving communication and social skills in a natural play environment. It empowers parents to actively participate in their child's therapy, which can lead to increased speech and social interaction in children with autism.12368

Research Team

IM

Isabel M Smith, PhD

Principal Investigator

IWK Health Centre and Dalhousie University

Eligibility Criteria

This trial is for preschoolers with autism spectrum disorder in Nova Scotia who show minimal response to standard treatments. They should have limited positive emotions, use fewer than 10 words spontaneously, and be about to enroll in the NS EI program. Children with severe sensory or motor impairments or whose parents can't consent in English are excluded.

Inclusion Criteria

Current spontaneous functional use of ≤ 10 words (clinician's observations; parent report using MacArthur-Bates Communicative Development Inventory - Words & Gestures (CDI-WG)
My child uses toys or objects less than expected.
Significant delay in cognitive abilities (assessed formally by psychologist or estimated by psychologist or developmental pediatrician at time of diagnosis)
See 2 more

Exclusion Criteria

I cannot complete the consent process or receive coaching in English.
My child has severe difficulties in feeling or moving.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Virtual Parent-Coaching Intervention

Parents receive virtual coaching in either PRIMeR or PRT strategies to enhance child responsivity

6 months
Virtual sessions

Follow-up

Participants are monitored for gains in social initiations and communication levels

6 months

Treatment Details

Interventions

  • PRIMeR (Behavioural Intervention)
  • PRT (Behavioural Intervention)
Trial OverviewThe study tests a brief parent-led intervention called PRIMeR aimed at increasing children's responsiveness to Pivotal Response Treatment (PRT), an existing method used by the publicly funded autism early intervention program in Nova Scotia.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: PRIMeRExperimental Treatment1 Intervention
Virtual parent coaching in use of a novel intervention consisting of Social Routines and Reciprocal Imitation Training strategies
Group II: PRTActive Control1 Intervention
Virtual parent coaching in use of Pivotal Response Treatment strategies

PRIMeR is already approved in Canada, China for the following indications:

🇨🇦
Approved in Canada as Pivotal Response Treatment for:
  • Autism Spectrum Disorder (ASD)
🇨🇳
Approved in China as Pivotal Response Treatment for:
  • Autism Spectrum Disorder (ASD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

IWK Health Centre

Lead Sponsor

Trials
131
Recruited
112,000+
Dr. Doug Sinclair profile image

Dr. Doug Sinclair

IWK Health Centre

Chief Medical Officer

MD from Dalhousie University

Dr. Krista Jangaard profile image

Dr. Krista Jangaard

IWK Health Centre

Chief Executive Officer since 2018

MD and Masters of Health Administration from Dalhousie University

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+

Dr. Paul C. Hébert

Canadian Institutes of Health Research (CIHR)

Chief Executive Officer

MD, University of Ottawa

Dr. Paul C. Hébert

Canadian Institutes of Health Research (CIHR)

Chief Medical Officer

MD, University of Ottawa

Findings from Research

Training parents to use the Natural Language Paradigm (NLP) effectively increased the frequency of verbalizations in their nonverbal and echolalic autistic children, demonstrating the method's efficacy.
After initial training in a clinic, parents successfully implemented NLP at home, leading to improvements in their children's speech across various settings, not just during training.
Training parents to use the natural language paradigm to increase their autistic children's speech.Laski, KE., Charlop, MH., Schreibman, L.[2019]
Pivotal response treatment (PRT) has been shown to be an effective intervention for improving communication and social functioning in children with autism spectrum disorder (ASD), based on a systematic evaluation of 17 studies.
The studies demonstrated strong adherence to several research quality standards, such as using standardized protocols and objective evaluators, but showed variability in treatment fidelity and the use of longitudinal designs, indicating areas for improvement in future research.
Pivotal response treatment for children with autism spectrum disorder: a systematic review of research quality.Cadogan, S., McCrimmon, AW.[2018]
Parents of children with autism spectrum disorder (ASD) found Pivotal Response Treatment with parent group training (PRT-PG) to be feasible and effective, reporting improvements in their child's social-communication skills and overall well-being.
The study highlighted that parents gained valuable insights into their child's needs and their own communication habits, which contributed to positive changes in family cohesion during the 14-week program.
Pivotal Response Treatment (PRT) - Parent Group Training for Young Children with Autism Spectrum Disorder: A Qualitative Study on Perspectives of Parents.de Korte, MWP., Kaijadoe, SPT., Buitelaar, JK., et al.[2022]

References

Training parents to use the natural language paradigm to increase their autistic children's speech. [2019]
Pivotal response treatment for children with autism spectrum disorder: a systematic review of research quality. [2018]
Pivotal Response Treatment (PRT) - Parent Group Training for Young Children with Autism Spectrum Disorder: A Qualitative Study on Perspectives of Parents. [2022]
Pivotal response treatment for infants at-risk for autism spectrum disorders: a pilot study. [2021]
Examining Effectiveness and Predictors of Treatment Response of Pivotal Response Treatment in Autism: An Umbrella Review and a Meta-Analysis. [2022]
A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism. [2022]
Pivotal Response Treatment for School-Aged Children and Adolescents with Autism Spectrum Disorder: A Randomized Controlled Trial. [2021]
Efficacy of a Parent-Implemented Pivotal Response Treatment for Children with Autism Spectrum Disorder. [2023]